New Weight Loss Drug

A new weight loss drug that can also curb compulsive behaviors and addictions is the result of marijuana research done in the 1990's.

Scientists studying marijuana found that the body naturally produces substances similar to cannabinoids (known as endocannabinoids) and knowing that smoking marijuana makes people hungry, scientists researched the effects of cutting down the activity of endocannabinoids. Their results showed that it helped diminish the body cravings for food.

Developed by Sanofi-Aventis, Acomplia (rimonabant) is already sold in a number of European countries, Argentina, Brazil, and Mexico. The FDA is scheduled to review the drug for the U.S. market on June 13th. If approved, it will be marketed in the U.S. under the name Zimulti.

Acomplia works on the brain’s pleasure center, disrupting the cycle of craving and satisfaction that is connected with compulsive behaviors and addictions. The drugs ability to curb compulsive behaviors is also why the drug helps people stop smoking without the associated weight gain. The drug reportedly reduces your appetite, enabling you to eat in small portions, and thereby lose weight in an effectual way.